TBPH Annual Total Liabilities
$169.00 M
+$3.40 M+2.06%
31 December 2023
Summary:
As of January 22, 2025, TBPH annual total liabilities is $169.00 million, with the most recent change of +$3.40 million (+2.06%) on December 31, 2023. During the last 3 years, it has fallen by -$603.80 million (-78.13%). TBPH annual total liabilities is now -78.13% below its all-time high of $772.81 million, reached on December 31, 2020.TBPH Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH Quarterly Total Liabilities
$170.45 M
+$2.11 M+1.25%
30 September 2024
Summary:
As of January 22, 2025, TBPH quarterly total liabilities is $170.45 million, with the most recent change of +$2.11 million (+1.25%) on September 30, 2024. Over the past year, it has increased by +$2.99 million (+1.79%). TBPH quarterly total liabilities is now -77.97% below its all-time high of $773.72 million, reached on September 30, 2020.TBPH Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.1% | +1.8% |
| 3 y3 years | -78.1% | -76.5% |
| 5 y5 years | -72.4% | -77.9% |
TBPH Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.3% | +2.1% | -76.1% | +2.9% |
| 5 y | 5-year | -78.1% | +2.1% | -78.0% | +2.9% |
| alltime | all time | -78.1% | +300.4% | -78.0% | +435.9% |
Theravance Biopharma Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $170.45 M(+1.3%) |
| June 2024 | - | $168.34 M(+1.1%) |
| Mar 2024 | - | $166.44 M(-1.5%) |
| Dec 2023 | $169.00 M(+2.1%) | $169.00 M(+0.9%) |
| Sept 2023 | - | $167.46 M(+0.6%) |
| June 2023 | - | $166.47 M(-0.9%) |
| Mar 2023 | - | $167.99 M(+1.4%) |
| Dec 2022 | $165.60 M(-76.8%) | $165.60 M(-41.5%) |
| Sept 2022 | - | $282.92 M(-60.2%) |
| June 2022 | - | $710.57 M(+0.5%) |
| Mar 2022 | - | $706.81 M(-0.9%) |
| Dec 2021 | $713.39 M(-7.7%) | $713.39 M(-1.8%) |
| Sept 2021 | - | $726.70 M(-0.4%) |
| June 2021 | - | $729.63 M(-2.5%) |
| Mar 2021 | - | $748.33 M(-3.2%) |
| Dec 2020 | $772.81 M(+22.2%) | $772.81 M(-0.1%) |
| Sept 2020 | - | $773.72 M(+0.9%) |
| June 2020 | - | $766.67 M(+0.4%) |
| Mar 2020 | - | $763.35 M(+20.7%) |
| Dec 2019 | $632.67 M | $632.67 M(+0.7%) |
| Sept 2019 | - | $628.14 M(-0.2%) |
| June 2019 | - | $629.67 M(-2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $644.52 M(+5.3%) |
| Dec 2018 | $611.82 M(+87.5%) | $611.82 M(+59.2%) |
| Sept 2018 | - | $384.41 M(-0.7%) |
| June 2018 | - | $386.98 M(-7.1%) |
| Mar 2018 | - | $416.70 M(+27.7%) |
| Dec 2017 | $326.22 M(+12.9%) | $326.22 M(+8.0%) |
| Sept 2017 | - | $302.04 M(-0.2%) |
| June 2017 | - | $302.76 M(+2.9%) |
| Mar 2017 | - | $294.09 M(+1.8%) |
| Dec 2016 | $289.02 M(+406.6%) | $289.02 M(+394.8%) |
| Sept 2016 | - | $58.42 M(+10.4%) |
| June 2016 | - | $52.90 M(-3.1%) |
| Mar 2016 | - | $54.59 M(-4.3%) |
| Dec 2015 | $57.05 M(+18.9%) | $57.05 M(+63.2%) |
| Sept 2015 | - | $34.96 M(+9.9%) |
| June 2015 | - | $31.80 M(-11.1%) |
| Mar 2015 | - | $35.79 M(-25.4%) |
| Dec 2014 | $47.98 M(+13.7%) | $47.98 M(+14.6%) |
| Sept 2014 | - | $41.88 M(-8.6%) |
| June 2014 | - | $45.83 M(+4.0%) |
| Mar 2014 | - | $44.08 M(+4.4%) |
| Dec 2013 | $42.21 M | $42.21 M |
FAQ
- What is Theravance Biopharma annual total liabilities?
- What is the all time high annual total liabilities for Theravance Biopharma?
- What is Theravance Biopharma annual total liabilities year-on-year change?
- What is Theravance Biopharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Theravance Biopharma?
- What is Theravance Biopharma quarterly total liabilities year-on-year change?
What is Theravance Biopharma annual total liabilities?
The current annual total liabilities of TBPH is $169.00 M
What is the all time high annual total liabilities for Theravance Biopharma?
Theravance Biopharma all-time high annual total liabilities is $772.81 M
What is Theravance Biopharma annual total liabilities year-on-year change?
Over the past year, TBPH annual total liabilities has changed by +$3.40 M (+2.06%)
What is Theravance Biopharma quarterly total liabilities?
The current quarterly total liabilities of TBPH is $170.45 M
What is the all time high quarterly total liabilities for Theravance Biopharma?
Theravance Biopharma all-time high quarterly total liabilities is $773.72 M
What is Theravance Biopharma quarterly total liabilities year-on-year change?
Over the past year, TBPH quarterly total liabilities has changed by +$2.99 M (+1.79%)